✦ LIBER ✦

In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007–2009 study

✍ Scribed by James A. Karlowsky; Heather J. Adam; Susan M. Poutanen; Daryl J. Hoban; George G. Zhanel

Book ID: 116409066
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 159 KB
Volume: 69
Category: Article
ISSN: 0732-8893
DOI: 10.1016/j.diagmicrobio.2010.10.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter evaluation of the in vitro a

Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)

✍ Douglas J. Biedenbach; Ronald N. Jones 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB

In Vitro Activity of Colistin (Polymyxin

In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008

✍ Walkty, A.; DeCorby, M.; Nichol, K.; Karlowsky, J. A.; Hoban, D. J.; Zhanel, G. 📂 Article 📅 2009 🏛 American Society for Microbiology 🌐 English ⚖ 141 KB

Analysis of 3789 in- and outpatient Esch

Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada—results of the CANWARD 2007–2009 study

✍ Philippe R.S. Lagacé-Wiens; Patricia J. Simner; Kevin R. Forward; Franil Tailor; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 158 KB

In vitro activity of ceftobiprole agains

In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007–2009 study

✍ Andrew Walkty; Heather J. Adam; Michel Laverdière; James A. Karlowsky; Daryl J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

In vitro activity of telavancin against

In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies

✍ Kevin M. Krause; Steven L. Barriere; Michael M. Kitt; Bret M. Benton 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 178 KB

P67 Antimicrobial resistance in pathogen

P67 Antimicrobial resistance in pathogens isolated from Canadian hospital clinics (C), emergency rooms (ER), medical/surgical wards (W) and intensive care units (ICU): results of the CANWARD 2008 study

✍ M. Decorby; B. Weshnoweski; R. Vashisht; F. Tailor; E. Turner-Brannen; M. McCrac 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB